Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chang Ji An capsule in diarrhea-predominant IBS (liver qi stagnation and spleen deficiency)
CTR20160031Phase 2Suspended
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Feb 2016
- Countries
- 1
01
Overview
A Phase 2 trial of Changji'an Capsule in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Started Feb 2016; status: suspended.
02
Drugs
Changji'an Capsule
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20160031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160031.